Department of Orthopedics, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China.
Health Science Center, Peking University, Beijing, China.
Radiat Oncol. 2021 Jan 22;16(1):21. doi: 10.1186/s13014-020-01740-y.
Most previous studies focused on the minimum interval between surgery and radiotherapy in spinal metastases, leaving the maximum interval under-investigated. However, in real world, limited radiotherapist and equipment cannot meet the needs of a large patient population to obtain timely radiotherapy after the index spine surgery in developing countries. This study aimed to estimate the clinical risks of delayed radiotherapy after surgery in patients with spinal metastases in developing country.
Data from 89 patients who underwent surgery and postoperative radiotherapy at a single site in a developing country were retrospectively reviewed. Patients were divided into the progression before radiotherapy (PBR) and no progression before radiotherapy (NPBR) groups. Kaplan-Meier analysis and log-rank tests were used to compare the local control (LC) and overall survival (OS) between groups.
Within 1 month after surgery, only 20.2% of patients underwent radiotherapy. Risk of local progression before radiotherapy at 1, 3, and 6 months was 1.2%, 24.1%, and 45.1%, respectively. The LC rate at 1 year was lower in the PBR group than in the NPBR group (53.3% vs. 76.3%, P = 0.040). The OS rate at 1 year was 61.9% and 79.6% in the PBR and NPBR groups, respectively (P = 0.001). The Karnofsky performance status significantly improved only in the NPBR group (52.5 ± 17.6 vs. 66.8 ± 26.3, P < 0.001). The sphincter dysfunction significantly improved in the NPBR group (0.3 ± 0.5 vs. 0.1 ± 0.3, P = 0.007) but it tended to be deteriorated in the PBR group (0.1 ± 0.4 vs. 0.3 ± 0.5, P = 0.500).
In real world, about 80% of patients had delayed radiotherapy 1 month after spine surgery for metastases in our developing country. Patients had a higher risk for radiographic local progression before radiotherapy and poorer LC, OS, and quality of life as time to radiotherapy increased.
大多数先前的研究都集中在脊柱转移瘤手术和放疗之间的最短时间间隔上,而最长时间间隔则研究较少。然而,在现实世界中,发展中国家有限的放射治疗师和设备无法满足大量患者在索引脊柱手术后及时获得放疗的需求。本研究旨在评估发展中国家脊柱转移瘤患者手术后延迟放疗的临床风险。
回顾性分析了在发展中国家的一个单一地点接受手术和术后放疗的 89 名患者的数据。患者分为放疗前进展(PBR)和放疗前无进展(NPBR)组。采用 Kaplan-Meier 分析和对数秩检验比较两组之间的局部控制(LC)和总生存(OS)。
术后 1 个月内,仅 20.2%的患者接受了放疗。放疗前 1、3 和 6 个月局部进展的风险分别为 1.2%、24.1%和 45.1%。PBR 组 1 年 LC 率低于 NPBR 组(53.3%比 76.3%,P=0.040)。PBR 组和 NPBR 组 1 年 OS 率分别为 61.9%和 79.6%(P=0.001)。Karnofsky 表现状态仅在 NPBR 组显著改善(52.5±17.6 比 66.8±26.3,P<0.001)。NPBR 组的括约肌功能障碍显著改善(0.3±0.5 比 0.1±0.3,P=0.007),而 PBR 组则有恶化趋势(0.1±0.4 比 0.3±0.5,P=0.500)。
在现实世界中,在我们的发展中国家,约 80%的脊柱转移瘤患者在手术后 1 个月后接受延迟放疗。随着放疗时间的延长,患者在放疗前出现影像学局部进展的风险更高,局部控制率、总生存率和生活质量更差。